September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Mechanism of action of mineralocorticoid receptor in the retina: evidences from transcriptomic analyses
Author Affiliations & Notes
  • Francine F Behar-Cohen
    Department of Ophthalmology, Jules Gonin Eye Hospital, Lausanne 7, Switzerland
    UMR_S 1138, INSERM, Paris, France
  • Marylin Der Nigoghossian
    UMR_S 1138, INSERM, Paris, France
    Centre de Recherche des Cordeliers, Paris, France
  • Rinath Levy
    UMR_S 1138, INSERM, Paris, France
    Centre de Recherche des Cordeliers, Paris, France
  • Min Zhao
    UMR_S 1138, INSERM, Paris, France
    Centre de Recherche des Cordeliers, Paris, France
  • Charlotte Andrieu-Soler
    UMR_S 1138, INSERM, Paris, France
    Centre de Recherche des Cordeliers, Paris, France
  • Footnotes
    Commercial Relationships   Francine Behar-Cohen, None; Marylin Der Nigoghossian, None; Rinath Levy, None; Min Zhao, None; Charlotte Andrieu-Soler, None
  • Footnotes
    Support  Swiss National Science Foundation grant
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Francine F Behar-Cohen, Marylin Der Nigoghossian, Rinath Levy, Min Zhao, Charlotte Andrieu-Soler; Mechanism of action of mineralocorticoid receptor in the retina: evidences from transcriptomic analyses. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : After showing that the retina is a mineralosensitive tissue responding to mineralocorticoid receptor (MR) by choroid dilation through SK3 (KCA2.3) overexpression in the choroidal vessels, we have proposed mineralocorticoid receptor antagonists (MRA) to reduce subretinal fluid in non-resolutive central serous chorioretinopathy (CSCR). The exact mechanisms of action of MRA on the neuroretina under physiologic or pathogenic conditions have not been fully explored. Our aim was to analyze the transcriptional effects of aldosterone or spironolactone on the normal rat retina.

Methods : Adult female Lewis rats were sacrificed 24h after intravitreous injections (5µl) of either aldosterone, spironolactone or the control vehicle (0,9% NaCl, 0,01% ethanol). Total RNA was isolated from the neuroretinas. 3 per condition were prepared for RNA-sequencing. Sequences were aligned to the rat genome. The regulated genes evidenced by RNA-sequencing were further validated by quantitative PCR using fluorescent DNA binding dye detection. The HPRT1 was used as an internal control.

Results : 31 genes were significantly regulated by aldosterone, most of them being down-regulated and 2 being up-regulated. Seven genes (22%) contribute to angiogenesis (Col4A3, Col4A5, Col4A2, Col1A2, Col9A2, Wls, Metml), 8 genes (25%) encode for proteins involved in ion and water transport and edema. 30% of the regulated genes were enriched in the human macula. Lcn2 was up-regulated by aldosterone as expected.
After spironolactone injection, 127 genes were regulated, 13 were up-regulated and 114 were down-regulated. Spironolactone regulated crystalline family genes, Scl family, aquaporin and ocular specific genes. Lcn2 and galectin-associated protein were down-regulated as expected.

Conclusions : MR agonist and antagonist regulate specific and different genes. Expected MR targets were found and new genes were identified, particularly those involved in angiogenesis, ion and water channel transport, osmoregulator and inflammation and oxidative stress, supposing anti-edematous effect of MRA independently from VEGF pathway. In addition to CSCR, MRA could have other applications taking into account that inflammation/ angiogenesis/ edema gene expression pathways are regulated in the neuroretina.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×